Cargando…
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123369/ https://www.ncbi.nlm.nih.gov/pubmed/34020162 http://dx.doi.org/10.1016/j.thromres.2021.05.006 |
| _version_ | 1783692884802797568 |
|---|---|
| author | Ageno, Walter De Candia, Erica Iacoviello, Licia Di Castelnuovo, Augusto |
| author_facet | Ageno, Walter De Candia, Erica Iacoviello, Licia Di Castelnuovo, Augusto |
| author_sort | Ageno, Walter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8123369 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81233692021-05-17 Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study Ageno, Walter De Candia, Erica Iacoviello, Licia Di Castelnuovo, Augusto Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2021-07 2021-05-15 /pmc/articles/PMC8123369/ /pubmed/34020162 http://dx.doi.org/10.1016/j.thromres.2021.05.006 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editors-in-Chief Ageno, Walter De Candia, Erica Iacoviello, Licia Di Castelnuovo, Augusto Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title | Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title_full | Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title_fullStr | Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title_full_unstemmed | Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title_short | Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study |
| title_sort | protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for covid-19: results from the corist study |
| topic | Letter to the Editors-in-Chief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123369/ https://www.ncbi.nlm.nih.gov/pubmed/34020162 http://dx.doi.org/10.1016/j.thromres.2021.05.006 |
| work_keys_str_mv | AT agenowalter protectiveeffectoforalanticoagulantdrugsinatrialfibrillationpatientsadmittedforcovid19resultsfromthecoriststudy AT decandiaerica protectiveeffectoforalanticoagulantdrugsinatrialfibrillationpatientsadmittedforcovid19resultsfromthecoriststudy AT iacoviellolicia protectiveeffectoforalanticoagulantdrugsinatrialfibrillationpatientsadmittedforcovid19resultsfromthecoriststudy AT dicastelnuovoaugusto protectiveeffectoforalanticoagulantdrugsinatrialfibrillationpatientsadmittedforcovid19resultsfromthecoriststudy AT protectiveeffectoforalanticoagulantdrugsinatrialfibrillationpatientsadmittedforcovid19resultsfromthecoriststudy |